These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 36136207)
1. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations. Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207 [TBL] [Abstract][Full Text] [Related]
2. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center. Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349 [TBL] [Abstract][Full Text] [Related]
3. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant Stoessel AM; Hale CM; Seabury RW; Miller CD; Steele JM J Pharm Pract; 2019 Aug; 32(4):442-446. PubMed ID: 29554847 [TBL] [Abstract][Full Text] [Related]
4. Innovative approaches to optimizing the delivery of vancomycin in individual patients. Pai MP; Neely M; Rodvold KA; Lodise TP Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Therapeutic Vancomycin Monitoring in Taiwan. Chen TT; Liu MP; Sun HC Microbiol Spectr; 2022 Apr; 10(2):e0156221. PubMed ID: 35412391 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data. Fewel N J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543 [TBL] [Abstract][Full Text] [Related]
7. Implementation of vancomycin AUC/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital. McClure S; McElroy L; Gugkaeva Z Am J Health Syst Pharm; 2024 May; 81(11):e283-e288. PubMed ID: 38253056 [TBL] [Abstract][Full Text] [Related]
8. Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia. Beccari MV; Seabury RW; Mogle BT; Kufel WD; Miller CD; Steele JM J Am Pharm Assoc (2003); 2020; 60(5):729-733. PubMed ID: 32224054 [TBL] [Abstract][Full Text] [Related]
9. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial. Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233 [TBL] [Abstract][Full Text] [Related]
10. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records. Chen Q; Wan J; Shen W; Lin W; Lin X; Huang Z; Lin M; Chen Y Pediatr Neonatol; 2022 May; 63(3):247-254. PubMed ID: 35190273 [TBL] [Abstract][Full Text] [Related]
11. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis. Zhang X; Wu Y; Wang D BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695 [TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review. Tkachuk S; Collins K; Ensom MHH Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350 [No Abstract] [Full Text] [Related]
14. Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients. Makmor-Bakry M; Ahmat A; Shamsuddin A; Lau CL; Ramli R Anaesthesiol Intensive Ther; 2019; 51(3):218-223. PubMed ID: 31434472 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies. Prybylski JP Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475 [TBL] [Abstract][Full Text] [Related]
16. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. Tsutsuura M; Moriyama H; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K BMC Infect Dis; 2021 Feb; 21(1):153. PubMed ID: 33549035 [TBL] [Abstract][Full Text] [Related]
17. The Safety and Efficacy of AUC/MIC-Guided vs Trough-Guided Vancomycin Monitoring Among Veterans. Folkers A; Anderson R; Harris J; Rogen C Fed Pract; 2023 Jan; 40(1):28-33. PubMed ID: 37223240 [TBL] [Abstract][Full Text] [Related]
18. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357 [TBL] [Abstract][Full Text] [Related]
19. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection? Hale CM; Seabury RW; Steele JM; Darko W; Miller CD J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results. Kim B; Hwang S; Heo E; Kim HS; Jung J; Kim ES; Kim HB; Lee K; Park JS; Song J; Lee JH; Chung JY; Song KH; Yoon S J Korean Med Sci; 2023 Apr; 38(14):e101. PubMed ID: 37038640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]